NewsGaming stocksPCPlayStationXboxRemedy EntertainmentCONTROL ResonantMax Payne
Remedy revenue triples in CONTROL Resonant launch quarter
The company posted a small operating profit but a net loss. Its results include the game's first seven days of sales.
Remedy Entertainment’s revenue rose to €39.6 million in the third quarter of 2026, up from €12.2 million a year earlier. The company attributed the 226% increase to sales of CONTROL Resonant, including preorders and the first seven days of sales after its September 24 launch.
In its unaudited business review released today, Remedy reported an operating profit of €0.6 million, compared with an operating loss of €16.4 million a year earlier. Its net result for the quarter was a €0.1 million loss.
Game sales and royalties accounted for €35.3 million in revenue, while development fees brought in another €4.3 million. Remedy said the fees came from the Max Payne 1&2 remake and the final development fee for CONTROL Resonant under its agreement with Annapurna Pictures.
On October 15, after the quarter ended, Remedy announced that CONTROL Resonant had passed one million copies sold worldwide, three weeks after launch. The company says it is the fastest-selling game in its history.
The Max Payne 1&2 remake is in full production, according to the review. An unnamed new project is at the production readiness stage.
Comments